The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Companion Diagnostic Tests Market Research Report 2025
Synopsis
The global Companion Diagnostic Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Tests.
Report Scope
The Companion Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffman LA Roche Ltd.
QIAGEN, Illumina, Inc.
Abbott
Agilent Technologies, Inc.
Genomic Health, Inc.
BioMerieux SA, BioGenex
AGENDIA NV
Siemens Healthcare GmBH
Thermo Fisher Scientific, Inc.
Segment by Type
Protein Detection
DNA Detection
Hybridization
Biomarker
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Companion Diagnostic Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Tests.
Report Scope
The Companion Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffman LA Roche Ltd.
QIAGEN, Illumina, Inc.
Abbott
Agilent Technologies, Inc.
Genomic Health, Inc.
BioMerieux SA, BioGenex
AGENDIA NV
Siemens Healthcare GmBH
Thermo Fisher Scientific, Inc.
Segment by Type
Protein Detection
DNA Detection
Hybridization
Biomarker
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein Detection
1.2.3 DNA Detection
1.2.4 Hybridization
1.2.5 Biomarker
1.2.6 Others
1.3 Market by Application
1.3.1 Global Companion Diagnostic Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Tests Market Perspective (2019-2030)
2.2 Companion Diagnostic Tests Growth Trends by Region
2.2.1 Global Companion Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Diagnostic Tests Historic Market Size by Region (2019-2024)
2.2.3 Companion Diagnostic Tests Forecasted Market Size by Region (2025-2030)
2.3 Companion Diagnostic Tests Market Dynamics
2.3.1 Companion Diagnostic Tests Industry Trends
2.3.2 Companion Diagnostic Tests Market Drivers
2.3.3 Companion Diagnostic Tests Market Challenges
2.3.4 Companion Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests Players by Revenue
3.1.1 Global Top Companion Diagnostic Tests Players by Revenue (2019-2024)
3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Tests Revenue
3.4 Global Companion Diagnostic Tests Market Concentration Ratio
3.4.1 Global Companion Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests Revenue in 2023
3.5 Companion Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Tests Breakdown Data by Type
4.1 Global Companion Diagnostic Tests Historic Market Size by Type (2019-2024)
4.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2025-2030)
5 Companion Diagnostic Tests Breakdown Data by Application
5.1 Global Companion Diagnostic Tests Historic Market Size by Application (2019-2024)
5.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Diagnostic Tests Market Size (2019-2030)
6.2 North America Companion Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Diagnostic Tests Market Size by Country (2019-2024)
6.4 North America Companion Diagnostic Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostic Tests Market Size (2019-2030)
7.2 Europe Companion Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Diagnostic Tests Market Size by Country (2019-2024)
7.4 Europe Companion Diagnostic Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Tests Market Size (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Diagnostic Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Diagnostic Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Tests Market Size (2019-2030)
9.2 Latin America Companion Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Diagnostic Tests Market Size by Country (2019-2024)
9.4 Latin America Companion Diagnostic Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Tests Market Size (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Diagnostic Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Diagnostic Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffman LA Roche Ltd.
11.1.1 F. Hoffman LA Roche Ltd. Company Detail
11.1.2 F. Hoffman LA Roche Ltd. Business Overview
11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Introduction
11.1.4 F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2019-2024)
11.1.5 F. Hoffman LA Roche Ltd. Recent Development
11.2 QIAGEN, Illumina, Inc.
11.2.1 QIAGEN, Illumina, Inc. Company Detail
11.2.2 QIAGEN, Illumina, Inc. Business Overview
11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Introduction
11.2.4 QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024)
11.2.5 QIAGEN, Illumina, Inc. Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Companion Diagnostic Tests Introduction
11.3.4 Abbott Revenue in Companion Diagnostic Tests Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Introduction
11.4.4 Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 Genomic Health, Inc.
11.5.1 Genomic Health, Inc. Company Detail
11.5.2 Genomic Health, Inc. Business Overview
11.5.3 Genomic Health, Inc. Companion Diagnostic Tests Introduction
11.5.4 Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024)
11.5.5 Genomic Health, Inc. Recent Development
11.6 BioMerieux SA, BioGenex
11.6.1 BioMerieux SA, BioGenex Company Detail
11.6.2 BioMerieux SA, BioGenex Business Overview
11.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Introduction
11.6.4 BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2019-2024)
11.6.5 BioMerieux SA, BioGenex Recent Development
11.7 AGENDIA NV
11.7.1 AGENDIA NV Company Detail
11.7.2 AGENDIA NV Business Overview
11.7.3 AGENDIA NV Companion Diagnostic Tests Introduction
11.7.4 AGENDIA NV Revenue in Companion Diagnostic Tests Business (2019-2024)
11.7.5 AGENDIA NV Recent Development
11.8 Siemens Healthcare GmBH
11.8.1 Siemens Healthcare GmBH Company Detail
11.8.2 Siemens Healthcare GmBH Business Overview
11.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Introduction
11.8.4 Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2019-2024)
11.8.5 Siemens Healthcare GmBH Recent Development
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Detail
11.9.2 Thermo Fisher Scientific, Inc. Business Overview
11.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Introduction
11.9.4 Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024)
11.9.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Companion Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Protein Detection
Table 3. Key Players of DNA Detection
Table 4. Key Players of Hybridization
Table 5. Key Players of Biomarker
Table 6. Key Players of Others
Table 7. Global Companion Diagnostic Tests Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Companion Diagnostic Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Companion Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Companion Diagnostic Tests Market Share by Region (2019-2024)
Table 11. Global Companion Diagnostic Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Companion Diagnostic Tests Market Share by Region (2025-2030)
Table 13. Companion Diagnostic Tests Market Trends
Table 14. Companion Diagnostic Tests Market Drivers
Table 15. Companion Diagnostic Tests Market Challenges
Table 16. Companion Diagnostic Tests Market Restraints
Table 17. Global Companion Diagnostic Tests Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Companion Diagnostic Tests Market Share by Players (2019-2024)
Table 19. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests as of 2023)
Table 20. Ranking of Global Top Companion Diagnostic Tests Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Companion Diagnostic Tests Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Diagnostic Tests Product Solution and Service
Table 24. Date of Enter into Companion Diagnostic Tests Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Companion Diagnostic Tests Revenue Market Share by Type (2019-2024)
Table 28. Global Companion Diagnostic Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Companion Diagnostic Tests Revenue Market Share by Type (2025-2030)
Table 30. Global Companion Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Companion Diagnostic Tests Revenue Market Share by Application (2019-2024)
Table 32. Global Companion Diagnostic Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Companion Diagnostic Tests Revenue Market Share by Application (2025-2030)
Table 34. North America Companion Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Companion Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Companion Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Companion Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Companion Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Companion Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Companion Diagnostic Tests Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Companion Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Companion Diagnostic Tests Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Companion Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Companion Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Companion Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Companion Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Companion Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Companion Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
Table 49. F. Hoffman LA Roche Ltd. Company Detail
Table 50. F. Hoffman LA Roche Ltd. Business Overview
Table 51. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product
Table 52. F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 53. F. Hoffman LA Roche Ltd. Recent Development
Table 54. QIAGEN, Illumina, Inc. Company Detail
Table 55. QIAGEN, Illumina, Inc. Business Overview
Table 56. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product
Table 57. QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 58. QIAGEN, Illumina, Inc. Recent Development
Table 59. Abbott Company Detail
Table 60. Abbott Business Overview
Table 61. Abbott Companion Diagnostic Tests Product
Table 62. Abbott Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 63. Abbott Recent Development
Table 64. Agilent Technologies, Inc. Company Detail
Table 65. Agilent Technologies, Inc. Business Overview
Table 66. Agilent Technologies, Inc. Companion Diagnostic Tests Product
Table 67. Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 68. Agilent Technologies, Inc. Recent Development
Table 69. Genomic Health, Inc. Company Detail
Table 70. Genomic Health, Inc. Business Overview
Table 71. Genomic Health, Inc. Companion Diagnostic Tests Product
Table 72. Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 73. Genomic Health, Inc. Recent Development
Table 74. BioMerieux SA, BioGenex Company Detail
Table 75. BioMerieux SA, BioGenex Business Overview
Table 76. BioMerieux SA, BioGenex Companion Diagnostic Tests Product
Table 77. BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 78. BioMerieux SA, BioGenex Recent Development
Table 79. AGENDIA NV Company Detail
Table 80. AGENDIA NV Business Overview
Table 81. AGENDIA NV Companion Diagnostic Tests Product
Table 82. AGENDIA NV Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 83. AGENDIA NV Recent Development
Table 84. Siemens Healthcare GmBH Company Detail
Table 85. Siemens Healthcare GmBH Business Overview
Table 86. Siemens Healthcare GmBH Companion Diagnostic Tests Product
Table 87. Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 88. Siemens Healthcare GmBH Recent Development
Table 89. Thermo Fisher Scientific, Inc. Company Detail
Table 90. Thermo Fisher Scientific, Inc. Business Overview
Table 91. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product
Table 92. Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2019-2024) & (US$ Million)
Table 93. Thermo Fisher Scientific, Inc. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Companion Diagnostic Tests Market Share by Type: 2023 VS 2030
Figure 3. Protein Detection Features
Figure 4. DNA Detection Features
Figure 5. Hybridization Features
Figure 6. Biomarker Features
Figure 7. Others Features
Figure 8. Global Companion Diagnostic Tests Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Companion Diagnostic Tests Market Share by Application: 2023 VS 2030
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. Research Institutes Case Studies
Figure 13. Companion Diagnostic Tests Report Years Considered
Figure 14. Global Companion Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Companion Diagnostic Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Companion Diagnostic Tests Market Share by Region: 2023 VS 2030
Figure 17. Global Companion Diagnostic Tests Market Share by Players in 2023
Figure 18. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests Revenue in 2023
Figure 20. North America Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Companion Diagnostic Tests Market Share by Country (2019-2030)
Figure 22. United States Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Companion Diagnostic Tests Market Share by Country (2019-2030)
Figure 26. Germany Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Companion Diagnostic Tests Market Share by Region (2019-2030)
Figure 34. China Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Companion Diagnostic Tests Market Share by Country (2019-2030)
Figure 42. Mexico Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Companion Diagnostic Tests Market Share by Country (2019-2030)
Figure 46. Turkey Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Companion Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. F. Hoffman LA Roche Ltd. Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 49. QIAGEN, Illumina, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 52. Genomic Health, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 53. BioMerieux SA, BioGenex Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 54. AGENDIA NV Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 55. Siemens Healthcare GmBH Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 56. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
